Curbstone Financial Management Corp Abb Vie Inc. Transaction History

Curbstone Financial Management Corp

$458 Million
Q3 2024

A detailed history of Curbstone Financial Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Curbstone Financial Management Corp holds 10,543 shares of ABBV stock, worth $2.12 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

10,543

Previous 10,921 3.46%

Holding current value

$2.12 Million

Previous $1.87 Million 11.16%

% of portfolio

0.45%

Previous 0.42%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$163.84 - $199.33 $61,931 - $75,346	-378 Reduced 3.46%	10,543 $2.08 Million
Q2 2024 Jul 03, 2024	SELL	$154.79 - $180.76 $60,987 - $71,219	-394 Reduced 3.48%	10,921 $1.87 Million
Q1 2024 Apr 09, 2024	SELL	$159.82 - $182.1 $23,973 - $27,315	-150 Reduced 1.31%	11,315 $2.06 Million
Q4 2023 Jan 08, 2024	BUY	$137.6 - $154.97 $13,760 - $15,497	100 Added 0.88%	11,465 $1.78 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $26,718 - $30,930	-200 Reduced 1.73%	11,365 $1.69 Million
Q2 2023 Jul 05, 2023	SELL	$132.51 - $164.9 $33,127 - $41,225	-250 Reduced 2.12%	11,565 $1.56 Million
Q1 2023 May 12, 2023	SELL	$144.61 - $166.54 $28,922 - $33,308	-200 Reduced 1.66%	11,815 $1.88 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $435,676 - $522,490	-3,150 Reduced 20.77%	12,015 $1.94 Million
Q3 2022 Oct 05, 2022	SELL	$134.21 - $153.93 $3,221 - $3,694	-24 Reduced 0.16%	15,165 $2.04 Million
Q2 2022 Aug 04, 2022	SELL	$137.62 - $174.96 $360,289 - $458,045	-2,618 Reduced 14.7%	15,189 $2.33 Million
Q1 2022 Apr 18, 2022	BUY	$131.98 - $163.75 $19,797 - $24,562	150 Added 0.85%	17,807 $2.89 Million
Q4 2021 Jan 19, 2022	BUY	$107.43 - $135.93 $9,668 - $12,233	90 Added 0.51%	17,657 $2.39 Million
Q3 2021 Oct 06, 2021	BUY	$106.4 - $120.78 $32,345 - $36,717	304 Added 1.76%	17,567 $1.9 Million
Q2 2021 Jul 09, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 0.58%	17,263 $1.94 Million
Q1 2021 Apr 05, 2021	SELL	$102.3 - $112.62 $25,575 - $28,155	-250 Reduced 1.44%	17,163 $1.86 Million
Q4 2020 Jan 14, 2021	BUY	$80.49 - $108.67 $28,171 - $38,034	350 Added 2.05%	17,413 $1.87 Million
Q3 2020 Oct 02, 2020	SELL	$85.91 - $100.83 $26,116 - $30,652	-304 Reduced 1.75%	17,063 $1.5 Million
Q2 2020 Jul 10, 2020	SELL	$73.37 - $98.18 $40,353 - $53,999	-550 Reduced 3.07%	17,367 $1.71 Million
Q1 2020 Apr 20, 2020	SELL	$64.5 - $97.79 $48,375 - $73,342	-750 Reduced 4.02%	17,917 $1.37 Million
Q3 2019 Oct 18, 2019	BUY	$62.98 - $75.72 $12,596 - $15,144	200 Added 1.08%	18,667 $1.41 Million
Q2 2019 Jul 09, 2019	SELL	$65.7 - $83.98 $31,536 - $40,310	-480 Reduced 2.53%	18,467 $1.34 Million
Q1 2019 Apr 10, 2019	BUY	$77.14 - $90.79 $124,581 - $146,625	1,615 Added 9.32%	18,947 $1.53 Million
Q4 2018 Jan 09, 2019	SELL	$77.85 - $96.01 $17,127 - $21,122	-220 Reduced 1.25%	17,332 $1.6 Million
Q4 2018 Jan 08, 2019	BUY	$77.85 - $96.01 $17,127 - $21,122	220 Added 1.27%	17,552 $1.63 Million
Q3 2018 Oct 10, 2018	SELL	$88.91 - $98.84 $19,560 - $21,744	-220 Reduced 1.25%	17,332 $1.64 Million
Q2 2018 Jul 06, 2018	SELL	$89.78 - $106.23 $13,467 - $15,934	-150 Reduced 0.85%	17,552 $1.63 Million
Q1 2018 Apr 10, 2018	BUY	$92.01 - $123.21 $756,598 - $1.01 Million	8,223 Added 86.75%	17,702 $1.68 Million
Q4 2017 Jan 08, 2018	SELL	$89.56 - $98.21 $947,813 - $1.04 Million	-10,583 Reduced 52.75%	9,479 $917,000
Q3 2017 Oct 03, 2017	BUY	$69.85 - $89.22 $1.4 Million - $1.79 Million	20,062	20,062 $1.78 Million

Others Institutions Holding ABBV

# of Institutions

3,760

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.83M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $356B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Curbstone Financial Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Curbstone Financial Management Corp with notifications on news.

Account

Curbstone Financial Management Corp Abb Vie Inc. Transaction History